Atlas Trials

Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis

Clinical trial NCT06011343 · UNKNOWN

Trial details

NCT number
NCT06011343
Sponsor
Hospital Universitário Professor Edgard Santos
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cutaneous Leishmaniasis, American
Start date
2023-10-01
Primary completion
2024-10-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.